Patents by Inventor Joyce Stellabott

Joyce Stellabott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Formulations of Antiviral Compounds
    Publication number: 20210361663
    Abstract: The present disclosure is directed to pharmaceutical formulations comprising an amorphous inhibitor of hepatitis C vims NS5A. These pharmaceutical formulations may be prepared by roller-compaction or wet-granulation methods. The present disclosure is also directed to oral dosage forms, such as tablets, comprising such pharmaceutical formulations.
    Type: Application
    Filed: October 21, 2019
    Publication date: November 25, 2021
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Sutthilug Sotthivirat, Joyce Stellabott, Walter R. Wasylaschuk
  • Pseudopolymorphs of an HCV NS5A inhibitor and uses thereof
    Patent number: 10167298
    Abstract: The present invention relates to novel Pseudopolymorphs of Compound A, compositions comprising at least one Pseudopolymorph of Compound A, and methods of using the Pseudopolymorphs of Compound A for preparing compositions useful for treating or preventing HCV infection in a patient, wherein Compound A has the structure.
    Type: Grant
    Filed: October 24, 2014
    Date of Patent: January 1, 2019
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Michael McNevin, Yong Liu, Ian Mangion, Alfred Lee, Joyce Stellabott, Benjamin D. Sherry, Gary Martin, Kung-I Feng, Scott Schultz, Ryan Cohen, Yanfeng Zhang
  • PSEUDOPOLYMORPHS OF AN HCV NS5A INHIBITOR AND USES THEREOF
    Publication number: 20160311834
    Abstract: The present invention relates to novel Pseudopolymorphs of Compound A, compositions comprising at least one Pseudopolymorph of Compound A, and methods of using the Pseudopolymorphs of Compound A for preparing compositions useful for treating or preventing HCV infection in a patient, wherein Compound A has the structure.
    Type: Application
    Filed: October 24, 2014
    Publication date: October 27, 2016
    Inventors: Michael McNEVIN, Yong LIU, Ian MANGION, Alfred LEE, Joyce STELLABOTT, Benjamin D. SHERRY, Gary MARTIN, Kung-I FENG, Scott SHULTZ, Ryan COHEN, Yanfeng ZHANG
  • Polymorphs of an androgen receptor modulator
    Patent number: 7365202
    Abstract: Compounds of structural formula I are modulators of the androgen receptor (AR) in a tissue selective manner.
    Type: Grant
    Filed: December 4, 2006
    Date of Patent: April 29, 2008
    Assignee: Merck & Co., Inc.
    Inventors: Lushi Tan, Robert S. Meissner, Wenjie Li, James J. Perkins, Aaron S. Cote, Joyce Stellabott, Yuan-Hon Kiang
  • Polymorphs of an androgen receptor modulator
    Publication number: 20070129548
    Abstract: Compounds of structural formula I are modulators of the androgen receptor (AR) in a tissue selective manner.
    Type: Application
    Filed: December 4, 2006
    Publication date: June 7, 2007
    Inventors: Lushi Tan, Robert Meissner, Wenjie Li, James Perkins, Aaron Cote, Joyce Stellabott, Yuan-Hon Kiang